DHL Group Acquires CRYOPDP to Boost Health Logistics Division

DHL Group has acquired 100% of CRYOPDP from Cryoport, Inc., a major provider of life sciences supply chain solutions. This move strengthens DHL’s “Health Logistics” division and expands its reach in the growing life sciences and healthcare sector.

CRYOPDP is a specialty courier company focused on clinical trials, biopharma, and cell and gene therapies. It operates in 15 countries and handles more than 600,000 shipments annually. Its services reach over 135 countries, providing essential white-glove logistics for critical healthcare needs.

The acquisition supports DHL’s strategy to grow its Life Sciences and Healthcare business, which already generated over EUR 5 billion in revenue in 2024. By integrating CRYOPDP, DHL enhances its Pharma Specialized Network with expert courier services and global air logistics support from DHL Express and DHL Global Forwarding.

Along with the acquisition, DHL Group and Cryoport announced a strategic partnership. The collaboration will combine DHL’s global logistics network with Cryoport’s niche expertise in temperature-controlled and time-sensitive shipments. It will also strengthen DHL’s ties with all Cryoport business units.

Oscar de Bok, CEO of DHL Supply Chain, called the acquisition a key step in expanding DHL’s pharma logistics. “We aim to meet the evolving needs of clinical trials, biopharma, and cell & gene therapies while expanding our footprint in traditional healthcare logistics,” he said.

Cryoport CEO Jerrell Shelton welcomed the partnership. He said the alliance opens new opportunities in key growth markets like Asia Pacific and EMEA. “Together, we will meet critical supply chain needs with enhanced solutions and wider global access,” he noted.

Also Read: DHL’s MEA Push to Boost Industrial Logistics.

This move supports DHL Group’s Strategy 2030, which prioritizes integrated, temperature-controlled solutions and end-to-end pharma logistics. The addition of CRYOPDP will help DHL reduce costs, improve service, and strengthen its leadership in advanced pharma logistics.

For Cryoport, the partnership with DHL will enable it to better execute its business in EMEA and APAC with a stronger focus on its core business in these regions, creating even greater opportunities to offer highly targeted, top-tier services in answering market demand for its services and products.